Treatment of Facial Flushing With Botulinum Toxin A Injections
Status: | Active, not recruiting |
---|---|
Conditions: | Other Indications, Other Indications |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 2/17/2019 |
Start Date: | August 2014 |
End Date: | December 2019 |
Treatment of Facial Flushing With Botulinum Toxin A Injections: A Split-Face, Double-blinded, Randomized Control Trial
The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat
facial flushing.
This study is a pilot study designed to determine feasibility of these procedures.
facial flushing.
This study is a pilot study designed to determine feasibility of these procedures.
Inclusion Criteria:
1. Patients 18-65 years of age with persistent facial flushing
2. Willing and have the ability to understand and provide informed consent for
participation in the study and are able to communicate with the study staff.
Exclusion Criteria:
1. Unable to understand the protocol or give informed consent
2. Younger than 18 or older than 65 years of age
3. Females who are pregnant or lactating
4. Known hypersensitivity to BTX-A
5. Subjects using medications that interfere with neuromuscular functions (such as
aminoglycoside antibiotics)
6. Subjects who have a history of congestive heart failure, carcinoid syndrome,
mastocystosis, or renal cell carcinoma
7. Botulinum toxin injections in the past 6 months
8. Ablative laser procedure in the past 6 months
9. Radiofrequency device treatment in the past 6 months
10. Ultrasound device treatment in the past 6 months
11. Medium to deep chemical peel in the past 6 months
12. Temporary soft tissue augmentation material in the area to be treated in the past year
13. Semi-permanent soft tissue augmentation material in the area to be treated in the past
2 years
14. Permanent soft tissue augmentation material in the area to be treated
15. Is planning to receive within the next 6 months, any cosmetic procedure (such as any
chemical peels, botulinum toxin injections, ablative or non-ablative laser procedures,
filler injections, radiofrequency procedures, dermabrasion, ultrasound and face
lifting procedures) in the forehead or glabellar region.
16. Is planning to use tretinoin or retinoic acid in the next 6 months
17. Has an active infection in the forehead or glabellar region (excluding mild acne)
18. Is allergic to cow's milk protein
19. Is allergic to albumin
20. Is currently using anticoagulation therapy
21. Has a history of bleeding disorders
We found this trial at
1
site
Chicago, Illinois 60611
Principal Investigator: Murad Alam, MD
Phone: 312-695-4761
Click here to add this to my saved trials